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ABSTRACT The highly conserved cochaperone DnaJ/Hsp40 family proteins are known to interact with molecular
chaperone Hsp70, and can regulate many cellular processes including protein folding, translocation, and
degradation. In studies of Caenorhabditis elegans locomotion mutants, we identified a gain-of-function (gf) muta-
tion in dnj-17 closely linked to the widely used e156 null allele of C. elegans GAD (glutamic acid decarboxylase)
unc-25. dnj-17 encodes a DnaJ protein orthologous to human DNAJA5. In C. elegansDNJ-17 is a cytosolic protein
and is broadly expressed in many tissues. dnj-17(gf) causes a single amino acid substitution in a conserved domain,
and behaves as a hypermorphic mutation. The effect of this dnj-17(gf) is most prominent in mutants lacking GABA
synaptic transmission. In a seizuremodel caused by amutation in the ionotropic acetylcholine receptor acr-2(gf), dnj-
17(gf) exacerbates the convulsion phenotype in conjunction with absence of GABA. Null mutants of dnj-17 show
mild resistance to aldicarb, while dnj-17(gf) is hypersensitive. These results highlight the importance of DnaJ proteins










Cells have molecular mechanisms to protect themselves from the stress
causedbymisfoldedoraggregatedproteins.DnaJ/Hsp40 familyproteins
are highly conserved through evolution and act as cochaperones by
interacting with and activating the ATPase activity of Hsp70 chaperone
proteins (Ohtsuka and Suzuki 2000; Qiu et al. 2006). Together, Hsp40
and Hsp70 help folding of nascent proteins and refolding and degra-
dation of misfolded proteins.
Accumulation of protein aggregation underlies various human dis-
eases including neurodegenerative diseases such as Parkinson’s disease
and Huntington’s disease (Muchowski and Wacker 2005; Sherman and
Goldberg 2001).Mutations in DnaJ/Hsp40 proteins have been associated
with such diseases, suggesting the importance of cochaperones in cellular
protein homeostasis (Blumen et al. 2012; Borrell-Pagès et al. 2006; Trinh
and Farrer 2013). In C. elegans, overexpression of polyglutamine repeats
in muscles or neurons causes formation of protein aggregation in an age-
dependent manner (Brignull et al. 2006a,b), similar to that observed in
human polyglutamine diseases (Sakahira et al. 2002). In addition, excess
excitatory neuronal signaling at the neuromuscular junction causes
locomotion defects and increased protein aggregation in muscles in a
C. elegans polyglutamine disease model, suggesting that neuronal activity
can affect protein homeostasis in other tissues (Garcia et al. 2007).
Functions of neural circuits depend critically on balanced activity
between excitatory and inhibitory transmission. In C. elegans, locomo-
tion is controlled by the coordinated activities of excitatory cholinergic
and inhibitory GABAergic motor neurons (Von Stetina et al. 2006).
GABA plays crucial roles in the nervous system of both vertebrates and
invertebrates. InC. elegans, mutants affectingGABA transmission were
isolated from forward genetic screens for locomotor defects (Brenner
1974; Jin et al. 1999;McIntire et al. 1993). TheC. elegans genes required
for GABA neurotransmission including unc-25/GAD (Jin et al. 1999),
unc-47/VGAT (McIntire et al. 1997), and unc-49/GABAAR (Bamber
et al. 1999; Richmond and Jorgensen 1999) are highly conserved among
animals. Analysis of unc-25/GADmutants has revealed that the canon-
ical reference allele unc-25(e156) causes a premature termination codon
(Trp383amber) in the enzymatic domain; e156 mutants completely
lack GABA immunoreactivity and have been widely used as represen-
tative of complete loss of GABA function.
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The nicotinic acetylcholine receptor subunit acr-2 is expressed in
the cholinergic motor neurons. A gain-of-functionmutation of acr-2
causes increased cholinergic motor neuron activity accompanied by
decreased GABAergic motor neuron activity, generating excitation–
inhibition (E/I) imbalance in locomotor circuit. acr-2(gf) animals ex-
hibit a characteristic repetitive convulsion behavior, the frequency
of which provides a quantitative measure of E/I imbalance (Jospin
et al. 2009; Stawicki et al. 2013).
Through studying the effects of defective GABAergic transmission
on acr-2(gf) animals, we unexpectedly found a gain-of-function muta-
tion in a cochaperone protein dnj-17 to be present in the widely used
strain CB156 unc-25(e156). We show that the DNJ-17 gain-of-function
mutation behaves in a hypermorphicmanner, and exacerbates excitation–
inhibition imbalance in acr-2(gf). Null mutations of dnj-17 exhibit mild
resistance to aldicarb, suggesting a role inmodulating neurotransmission.
Homologs of DNJ-17 include humanDNAJA5, which is expressed in the
brain and other tissues. Our findings provide insights into the in vivo
function of these cochaperone proteins.
MATERIALS AND METHODS
Strains
C. elegans strains were kept at 22.5 according to standard procedures.
Supplemental Material, Table S1 lists strain information with alleles
and transgenes. Galaxy platform (Giardine et al. 2005) and CloudMap
workflows (Minevich et al. 2012) were used to analyze the whole-
genome sequence data of MT6648 unc-25(e156) dnj-17(ju1162)III;
acr-2(n2420)X and CZ19995 unc-25(e156) dnj-17(ju1162)III;
acr-2(n2420)X, obtained by Beijing Genomics Institute (Shenzhen, China).
Subsequent analyses based on chromosomal linkage and recombina-
tion mapping identified the ju1162 missense mutation in dnj-17. We
verified the presence of dnj-17(ju1162) in CB156, and generated
CZ22168 unc-25(e156) that lacks dnj-17(ju1162) through multistep
recombination as follows: We verified that the Caenorhabditis
Genetics Center (CGC) strain SP1104 unc-25(e156) bli-5(e518)III
is wild type for dnj-17. We outcrossed SP1104 to N2, and isolated
recombinant animals that showed unc-25(0) shrinker phenotype without
blister phenotype. We performed genotyping on isogenic strains of the
recombinants, and confirmed the presence of unc-25(e156) and the loss
of bli-5(e518). In this process, we also found SP1104 has another muta-
tion linked to chromosome III that caused egg-laying defects. Through
further outcrossing to N2, we reisolated unc-25(e156) based on behavior
and genotyping and established strain CZ22168 which does not ex-
hibit the egg-laying defects. Primers used for PCR and genotyping
were as follows: YJ10801 CCGTAGAAACCATTCACAGTTTGC
and YJ10802 CTATGAAATGCCATTACGAAGTGCTC for dnj-
17(ju1162), YJ11985 CATTGGCGCAGACTATTGCTTC and
YJ11986 AATTGCTCACCGAAACTCACATTCT for unc-25(e156),
YJ10799 TACTTGGTATCCAGCTCCTTCC and YJ10800 ATTATT
TGGACAGTTTAGCCCACC for bli-5(e518). The information on the
alleles and CB156 is deposited in CGC and Wormbase. Several re-
searchers noted that unc-25(e156) appeared to behave differently from
other unc-25 alleles or GABA mutants, in a number of behavioral
and pharmacological assays (C. Bargmann, E. Jorgensen, S. Chalasani,
J. Kaplan, personal communications). For future experiments on
unc-25 mutants, we recommend CZ22168, as well as other unc-25
alleles.
Molecular biology and transgenes
Molecularbiologywasperformedfollowing standardmethods.Gateway
recombination technology (Invitrogen, CA) was used for expression
vectors. Table S2 describes the details of constructs generated in this
study. We amplified 3.5 kb genomic sequences of dnj-17 with 0.9 kb 59
upstream sequences to 0.1 kb 39 downstream region using the follow-
ing primers: YJ11121 AAACTCCATCAACCTGACTTCCCTG and
YJ11122 TTGCCCATTATTCTTCCCGAAAC. To determine the gene
structure of dnj-17, we isolated mRNAs frommixed-stage animals of N2
wild type andCB156 unc-25(e156) dnj-17(ju1162) using Trizol (Thermo-
Fisher Scientific). Complementary DNA (cDNA) synthesis was per-
formed using SuperScript III (ThermoFisher Scientific), with random
primers according to the manufacturers’ instructions. We performed
RT-PCR using SL1 primer GTTTAATTACCCAAGTTTGAG and
a reverse primer p3 GCGACCAGATTCCTAATTTGCTCGTTC
designed on the junction of exon 3 and exon 4 to determine the first
exon of dnj-17mRNA, and p2 ATGAAATGCCATTACGAAGTGCTC
and p4 AATGTTTCACCAATCCTCATCATCC primers designed on
the first and sixth exon to verify the coding sequence. Sequences of all
clones were verified by Sanger sequencing. Protein domain analysis was
performed using NCBI domain database (Marchler-Bauer et al. 2015)
and Treefam (Li et al. 2006).
Generation of deletion alleles of dnj-17 by CRISPR-
Cas9 editing
dnj-17(ju1239) and dnj-17(ju1276) deletion alleles were generated by
CRISPR-Cas9 editing in the germline, using modifications of previ-
ously described methods (Dickinson et al. 2013) (Z. Wang and Y.J.,
unpublished data). Briefly, adult animals were injected with the Cas9-
sgRNA expression constructs (pCZGY2647 and pCZGY2646, made
from pDD162 with sgRNA) and Pmyo-2-mCherry as a co-injection
marker. F1 animals expressing mCherry in pharynx were isolated,
allowed to lay eggs, and then genotyped for dnj-17 to detect dele-
tions. The F2 progeny of F1 animals with deletions were isolated to
establish strains containing dnj-17 deletion. sgRNA sequences used
to target dnj-17 are the following: ACAGAAAACTAGCGCTCAAA
and GAGTTTGGCGACAAGGATAC. ju1239 was generated fol-
lowing microinjection into N2 animals. ju1276 was generated fol-
lowing microinjection into CB156 unc-25(e156) animals.
Toanalyze the temperature effects ondnj-17(ju1239),we examined the
growth and locomotion of N2 and CZ21429 dnj-17(ju1239) under dif-
ferent temperature conditions. Briefly, 10 gravid adults of each strainwere
allowed to lay eggs for 6 hr at 22.5. Then, adult animals were removed,
and the plates with embryos were kept under 15, 22.5, or 25. Hatched
progeny were kept under the same temperature, and their growth and
general locomotionwere visually scored oncewithin 16224 hr.When the
progeny reached L4 stage, animals from each condition were placed onto
individual plates. Number of eggs laid by each animal was scored to
compare the brood size. The experiment was repeated twice.
Generation of single-copy inserted strains
Single-copy insertion transgenes ofPdnj-17-dnj-17(+) andPdnj-17-dnj-
17(ju1162) were generated at Chromosome II site ttTi5605 using mod-
ified vectors (Z. Wang and Y.J., unpublished data). Briefly, N2 young
adult animals were injected with the following constructs: a construct
(pCZGY3031 or pCZGY3032) containing dnj-17 sequence with
ttTi5605 homology arms and a copy of hygromycin resistance gene,
a construct (pDD122) which drives expression of Cas9 and sgRNA
targeting ttTi5605 in the germline, and a Pmyo-2-mCherry fluorescent
co-injection marker. F2 animals were selected for the resistance to
hygromycin. Single-copy insertion lines were confirmed by PCR using
primers designed outside of the homology arms. Loss of extrachromo-
somal array was confirmed by PCR and the loss of co-injection marker.
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Each insertion line was outcrossed twice before being used in
experiments.
Quantification of convulsion behavior
Scoring of convulsions was performed as previously described (Stawicki
et al. 2013). Briefly, L4 larvae were transferred to nematode growth
medium (NGM) plates seeded with Escherichia coli OP50. On the fol-
lowing day, young adults were transferred to fresh plates with OP50 and
visually scored for convulsion behavior under a dissecting microscope.
The observer was blinded to the genotype of the animals tested. A con-
vulsion eventwas defined as a shortening of the animal’s body length. The
assay was repeated at least twice per genotype in two different genera-
tions. Two independent transgenic lines were used for each construct.
Aldicarb assay
One day before the experiment, L4 animals were transferred to fresh
plates seeded with OP50. On the next day, 10 animals were transferred
to an NGM plate with 500 mM aldicarb. Animal behavior was scored
every 30 min. Animals were scored paralyzed when they did not move
for more than 5 sec in response to touch stimulus.
Confocal microscopy
L4 animals were imaged using a Zeiss LSM 710 confocal microscope
(63· objective). Animals were immobilized by 1 mM levamisole and
placed on 4% agar pads. Images are maximum-intensity projections of
z stacks obtained at 1 mm intervals. ImageJ was used to process the
images obtained.
Figure 1 Single amino acid substitution in DNJ-17 in the background of unc-25(e156) causes increase of acr-2(gf) convulsions. (A) Quantification
of convulsion frequency of strains with mutations in genes required for GABA transmission. Note the higher convulsion frequency of the animals
with unc-25(e156) dnj-17(ju1162). Statistics, one way ANOVA followed by Bonferroni’s post hoc test.  P , 0.05,  P , 0.001. Error bars indicate
SEM. Numbers in the column indicate sample sizes. (B) Upper panel shows dnj-17 gene structure, with the location of the ju1162 T to A nucleotide
change, deletion mutations, and primers (p1, p2: forward primer, p3, p4: reverse primer) designed for cDNA amplification. Lower panel shows
predicted DNJ-17 protein in wild type and in deletion mutants. All three mutations cause frameshift and produce premature stop codons. Note
that ju1239 and ju1276 remove the highly conserved DnaJ domain. Black fills designate frame-shifted regions. (C) Gel electrophoresis of the
cDNA fragments amplified by PCR using the designated primers (shown in B). SL1 with p3 primer amplified cDNA fragment including the start
codon. (D) Upper panel shows DNJ-17 family protein structure. D. m.: Drosophila melanogaster, M. m.: Mus musculus, H.s.: Homo sapiens. S.c.:
Saccharomyces cerevisiae. Lower panel shows amino acid sequence alignment around the DnaJ domain. , position of N to K mutation in ju1162;
y, HPD motif, highly conserved among the J domain and required for the activation of Hsp70 (Tsai and Douglas 1996; Meyer et al. 2007).
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Data availability
Strains and constructs are described in Table S1 and Table S2 respec-
tively, and are available upon request.
RESULTS AND DISCUSSION
Identification of a missense mutation in dnj-17 in
unc-25(e156) strains
acr-2(n2420gf) animals show spontaneous convulsion behavior, due to
increased cholinergic excitation and reduced GABAergic inhibition
(Jospin et al. 2009). We wanted to further examine the effects of
GABAergic transmission on the convulsive behavior of acr-2(gf) ani-
mals.We generated double mutants of acr-2(gf)with genes essential for
GABA signaling, using canonical or null alleles of unc-25/GAD, unc-47/
VGAT, unc-49/GABAR. We used three null mutations of unc-25: e156,
n2324, and n2328, which cause amber stop codons at Trp383, Trp291,
and Glu486, respectively, and which are all predicted to encode trun-
cated proteins that lack the cofactor binding site and enzymatic activity
site at the C-terminus. All double mutants showed increased convul-
sion frequency compared to acr-2(gf) singlemutants (Figure 1A).While
unc-25(n2324) and unc-25(n2328) enhanced acr-2(gf) behavioral de-
fects to similar degrees as unc-47(gk192) and unc-49(e382), unc-25(e156)
increased the convulsion frequency significantly more than these four
mutations. Further outcrossing of unc-25(e156); acr-2(gf) (MT6648) did
not eliminate this enhancement. We thus hypothesized that the ances-
tral CB156 strain may contain additional modifier mutation(s) linked
to unc-25(e156).
We performed whole-genome sequencing analysis of MT6648 and
of an outcrossed strain CZ19995 unc-25(e156); acr-2(gf). Following
chromosomal linkage mapping, we identified a single nucleotide trans-
version from thymine to adenine in the coding sequence of the gene
dnj-17, approximately 0.5map units right of unc-25 on chromosome III
(Figure 1B), and hereafter referred to as dnj-17(ju1162). The ju1162
mutation was present in the CGC strain CB156 unc-25(e156), but not in
SP1104 unc-25(e156) bli-5(e518) III, which was generated in about
1987 through recombination from trans-heterozygous animals of
unc-25(e156) with a chromosome containing bli-5(e518) (R. Herman,
personal communication). dnj-17(ju1162) was also not present in
MT5957 unc-25(n2324) III and MT5969 unc-25(n2328) III. Therefore,
dnj-17(ju1162) did not arise as a spontaneous mutation in strain pas-
sage in our laboratory, but was inherited from the original CB156 stock.
dnj-17 encodes a homolog of human DNAJA5
Gene structure (WormbaseWS251) showed that dnj-17 contains seven
exons, generating a mature mRNA predicted to encode a protein of
510 amino acids. To verify the dnj-17 gene structure we performed
cDNA analyses using mRNA isolated from N2 and CB156 unc-25(e156)
dnj-17(ju1162). RT-PCR analyses using SL1 and gene-specific pri-
mers revealed that the 59 end of dnj-17 mRNA contained an SL1
leader, but predicted exon 1 was not present in the mature mRNA.
We obtained full-length dnj-17 cDNA and found that DNJ-17 protein
consists of 485 amino acids (Figure 1, B and C). From NCBI protein
domain analysis, the N-terminus of DNJ-17 has a highly conserved
DnaJ domain, known to interact with Hsp70 family proteins, and the
C-terminal half contains two C2H2-type zinc finger motifs that have
been implicated to be important for polypeptide binding (Banecki
et al. 1996; Lu and Cyr 1998; Szabo et al. 1996). Relatives of DNJ-17
are found widely in eukaryotes, with orthologs named as JJJ1 in yeast,
DNAJA5/DNAJC21 in human, DNAJC21 in mouse, and CG2790 in
Drosophila (Figure 1D). The J domain of DNJ-17 also has a highly
conserved HPDmotif that is crucial for interaction with Hsp70 proteins
(Tsai and Douglas 1996). Yeast JJJ1 activates ATPase activity of Hsp70,
and lack of JJJ1 results in cold sensitivity (Meyer et al. 2007). On the other
hand, functions of the DNJ-17 family proteins in animals remain mostly
unknown, though human DNAJA5 is expressed in several tissues in-
cluding the brain (Chen et al. 2004). We confirmed that cDNAs from
Figure 2 dnj-17(ju1162) acts as a gain-of-function mutation. (A,C,D) Quantification of convulsion frequency. (A) Loss-of-function deletion
alleles of dnj-17 do not affect acr-2(gf) convulsion frequency. (C) Removal of dnj-17(ju1162gf) reduces the convulsion frequency. (D) dnj-
17(ju1162gf) shows semidominant effects on convulsion frequency. Statistics, one way ANOVA followed by Bonferroni’s post hoc test.  P ,
0.05. Numbers in the column indicate sample sizes. (B) Brood size is not affected by deletion of dnj-17. n = 6 for each condition. Error bars
indicate SEM.
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CB156 unc-25(e156) dnj-17(ju1162) contained a single nucleotide change,
which causes Asp77 to Lys amino acid substitution (N77K) in the
region immediately adjacent to the DnaJ domain (Figure 1, B and D).
dnj-17(ju1162) is a gain-of-function mutation
Several lines of evidence support that ju1162 is a gain-of-function
mutation of dnj-17. First, we examined the effect of a dnj-17 deletion
allele dnj-17(tm570), which removes the C-terminal half of the protein
(Figure 1B). dnj-17(tm570) homozygous animals showed normal
growth rate, wild-type locomotion, and did not affect convulsion fre-
quency of acr-2(gf) (Figure 2A). We also generated unc-47(gk192) dnj-
17(tm570); acr-2(n2420) triple mutants and found that they resembled
unc-47(gk192); acr-2(n2420) double mutants in their convulsion fre-
quency. As dnj-17(tm570)mutants potentially produce mRNAs encod-
ing a truncated protein with intact DnaJ domain, we next generated a
deletion allele targeting the DnaJ domain using CRISPR-Cas9-mediated
genome editing technology (Dickinson et al. 2013; Friedland et al.
2013) (Z. Wang and Y.J., unpublished results). dnj-17(ju1239) removes
a large portion of the DnaJ domain and is predicted to cause a frame-
shift and premature stop after amino acid 34 (Figure 1B). Since the null
mutation of a yeast protein with J domain, Jjj1, was previously reported
to cause cold sensitivity in yeast (Meyer et al. 2007), we examined the
viability and locomotion of dnj-17(ju1239) mutants. The mutant ani-
mals had similar brood size as wild type under three temperature
conditions (Figure 2B). Their growth rate, body shape, and movement
were also indistinguishable from wild type. Finally, dnj-17(ju1239) did
not affect the convulsion frequency of acr-2(n2420) (Figure 2A). These
observations show that dnj-17 is a nonessential gene for C. elegans
development and behavior, and that dnj-17 loss-of-function does not
affect convulsion of acr-2(gf) by itself or when GABA transmission is
eliminated in unc-47(null) animals.
We further examined if removing dnj-17(ju1162) from unc-25(e156)
background would eliminate the increased convulsion frequency phe-
notype of acr-2(gf). As dnj-17 is located 0.5map unit apart from unc-25,
it is challenging to separate unc-25(e156) and dnj-17(ju1239) by genetic
recombination. We therefore generated another deletion allele in the
unc-25(e156) dnj-17(ju1162) background using CRISPR editing (Figure
1B). dnj-17(ju1276) removed the DnaJ domain and the region includ-
ing ju1162(N77K), and eliminated the increased convulsion (Figure
2C). Furthermore, through isolation of unc-25(e156) recombinants af-
ter outcrossing SP1104 unc-25(e156) dnj-17(+) bli-5(e518), we obtained
CZ22169 unc-25(e156) dnj-17(+); acr-2(n2420). Animals of genotype
unc-25(e156) dnj-17(ju1276); acr-2(gf) and unc-25(e156) dnj-17(+);
acr-2(gf) showed convulsion frequencies lower than unc-25(e156)
dnj-17(ju1162); acr-2(gf), and instead resembled acr-2(gf) double
mutants with unc-25(n2324) or with other GABAmutants (Figure 2C).
Finally, we also observed that dnj-17(ju1162) showed semidominant
effects on convulsion frequency in the acr-2(gf); unc-25(0) background
(Figure 2D). Thus, we conclude that dnj-17(ju1162) is a semidominant
gain-of-function mutation, designated as dnj-17(ju1162gf).
DNJ-17 is a cytosolic protein expressed in
multiple tissues
We next analyzed the expression pattern of dnj-17. We first generated
an extrachromosomal transcriptional green fluorescent protein (GFP)
reporter using 0.9 kb promoter region of dnj-17. GFPwas seen through-
out the body with enrichment in the intestine and several cells around
the pharynx, and the expression pattern was similar in both wild type
and acr-2(gf) background (Figure 3A). We then made GFP-fused
translational DNJ-17 reporters. GFP signals from Pdnj-17-dnj-17::
gfp localized to the cytosol of head neurons, and in other unidentified
cells at lower levels throughout the body (Figure 3B). A weaker but
similar pattern was observed in an integrated fosmid expression line
which expresses DNJ-17 tagged with C-terminal TY1::EGFP:3xFLAG
(not shown) (Zhong et al. 2010). Moreover, DNJ-17(N77K)::GFP
showed similarly diffused expression. Both DNJ-17(+)::GFP and
DNJ-17(N77K) expression patterns were similar in wild type and in
acr-2(gf) background, suggesting that the presence of acr-2(gf) does
not largely affect the localization of DNJ-17.
DNJ-17(N77K) behaves as a hypermorph
We next examined the nature of DNJ-17(N77K) using transgenic over-
expression. Overexpression of wild-type dnj-17 by genomic sequence of
dnj-17 including 0.9 kb upstream promoter region caused increase of
acr-2(gf) convulsion frequency (Figure 4A). This transgene also en-
hanced convulsion frequency in unc-47(0) mutant background, sug-
gesting that the increase in convulsion by overexpression of dnj-17 is
independent of the effect caused by defects in GABAergic transmission.
Interestingly, this enhanced effect was also observed by overexpression
of dnj-17(ju1162gf). ACR-2 is expressed specifically in neurons (Jospin
et al. 2009). However, overexpression of dnj-17 wild type or ju1162(gf)
using the Prgef-1 pan-neuronal promoter did not affect convulsion
frequency of acr-2(gf) (Figure 4B). Also, overexpression in muscles
using Pmyo-3 promoter did not affect acr-2(gf) convulsion frequency
(Figure 4B). These results suggest that the effect of dnj-17 on convulsion
frequency likely requires its expression in multiple tissues.
To precisely compare the effect of dnj-17(ju1162gf) to wild-type dnj-
17, we generated a single-copy insertion transgene expressing full-length
genomic dnj-17(ju1162gf) or dnj-17(+) on chromosome II. Animals with
Pdnj-17-dnj-17(ju1162gf) expressed froma single-copy transgene showed
Figure 3 Expression pattern of DNJ-17 is not
affected by the N77K mutation or by acr-2(gf).
(A) Confocal images of animals expressing dnj-
17 transcriptional reporter. (B) Confocal images
of animals expressing DNJ-17 translational re-
porter. Scale bar: 50 mm. Arrowheads point to
expression in cell bodies of the head neurons.
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overall normal locomotion, growth speed, and brood size.We found that
Pdnj-17-dnj-17(ju1162gf);acr-2(gf) increased convulsion compared to
acr-2(gf) single mutants, whereas Pdnj-17-dnj-17(+) single-copy expres-
sion did not (Figure 4C), consistent with dnj-17(ju1162gf) acting semi-
dominantly in unc-25(e156) background (Figure 2D). These results
suggest that the DNJ-17(N77K) mutation has higher activity than
wild-type DNJ-17, implying that the increase in convulsion by overex-
pression of wild-type dnj-17 is caused by excess levels of the protein.
dnj-17 activity affects the response to aldicarb
To further assess the effect of dnj-17mutations on neurotransmission at
the neuromuscular junction, we examined the sensitivity of the mutant
animals to an acetylcholine esterase inhibitor aldicarb. dnj-17(ju1239)
null animals showed mild resistance to aldicarb, which was rescued by
single-copy insertion of dnj-17(+), implying that dnj-17 affects cholinergic
transmission at the neuromuscular junction (Figure 4D). Expression of
dnj-17(ju1162gf) caused mildly increased sensitivity to aldicarb, reach-
ing statistical significance at one time point, consistent with this allele
being a hypermorph mutation. These results raise a possibility that the
function of dnj-17 is required for folding and/or function of proteins in
multiple tissues that are involved in cholinergic transmission. Overex-
pression of wild-type DNJ-17 may also lead to a high level of cholinergic
transmission by contributing to folding of the proteins in the pathway.
Perspectives
Othermechanismsmight account for the effects of dnj-17(ju1162). The
N77K mutation may make DNJ-17 protein prone to form aggregates.
DnaJ/Hsp40 proteins bind to misfolded proteins and bring them to
Hsp70 (Cheetham and Caplan 1998). The N77K mutation could alter
the kinetics for DNJ-17 to detach from the protein(s) it binds to, and
prevent the misfolded protein from being degraded, resulting in accu-
mulation of misfolded proteins that cause cellular stress. Such cellular
stress could alter neuronal and muscular functions. Another possibility
is that the mutation disrupts certain cellular functions. Recently it was
reported that an Asn to Ser mutation in the DnaJ domain of human
DNAJC13 was found in a family with Parkinson disease, where the
disease was transmitted in an autosomal-dominant manner (Vilariño-
Güell et al. 2014). The mutant protein exhibited a toxic gain-of-function
activity affecting endosomal transport. The N77Kmutation in C. elegans
DNJ-17 may affect similar cellular functions such as endocytosis and
Figure 4 Single-copy expression of dnj-17(ju1162gf) is sufficient to cause increase in convulsion frequency. (A2C) Quantification of convulsion
frequency. (A) Overexpression of dnj-17(+) or dnj-17(ju1162gf) by high-copy extrachromosomal arrays causes increase of acr-2(gf) convulsion
frequency. (B) Neuron- or muscle-specific overexpression of dnj-17 does not affect convulsion frequency. (C) Single-copy expression of dnj-
17(ju1162gf), but not dnj-17(+), causes increase in convulsion frequency. Statistics, one way ANOVA followed by Bonferroni’s post hoc test.  P ,
0.05. Error bars indicate SEM. Numbers in the column indicate sample sizes. (D) Aldicarb resistance of dnj-17(ju1239) null is suppressed by
expression of single-copy wild-type dnj-17. dnj-17(ju1239) animals with single-copy expression of dnj-17(ju1162gf) showed mildly increased
sensitivity to aldicarb. Statistics, two way ANOVA.  P , 0.05 compared to N2 at the given time point.
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subcellular trafficking, thus disrupting the coordination of the motor
neuron circuit.
E. coli has only one gene coding DnaJ/Hsp40, whereas animals typ-
ically expressmultiple DnaJ familymembers. The DnaJ protein in E. coli
has been well characterized, but functions of individual DnaJ/Hsp40
family proteins in animals remain largely unknown. DNAJA5, the clos-
est human homolog of DNJ-17, shows enhanced expression in the brain
(Chen et al. 2004) which suggests neuron-specific roles, but its substrates
and functions are yet to be characterized. Studies of DnaJ/Hsp40 in
animals may lead to further understanding of the physiological mech-
anisms of protein homeostasis in neurodegenerative diseases.
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